GTCbio and the advisory board would like to invite you to the 2016 Diabetes Summit to be held April 25-27, 2016 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently:

9th Diabetes Drug Discovery & Development Conference
Sessions include:
Joint Session: Stem Cell Research in the Diabetes Space
I. New Discoveries and Emerging Therapies for Type 1 Diabetes
II. Advances and Strategies in Drug Development
III. Novel Therapeutic Targets & Strategies for Diabetes Treatment
IV. New Discoveries and Treatment for Type 2 Diabetes

6th Diabetes Partnering & Deal-Making Conference
Panels include:
I. Equity Markets and Investment Trends in Diabetes and Obesity
II. Diabetes Deal-Making: Current Trends and Future Predictions
III. What Is Pharma Seeking?
IV. Models for Successful Partnerships among Academia, Government, and Industry
V. Driving Innovations and the Effect on Partnering and Deal-Making
VI. Biotech Showcase: New Approaches, Emerging Pipelines

Experts from industry and academia will discuss the bionic pancreas, bariatric surgery, the gut microbiome, obesity, and emerging therapies to target Type 1 and Type 2 diabetes in sessions and panels geared towards novel therapeutic strategies, drug discovery, and partnering with pharmaceuticals, biotech firms, and academic institutions.